Kazem Rahimi
@kazemr
Cardiologist, epidemiologist, health informatics, e-health, director of deep medicine programme at Oxford University
14-02-2011 08:03:56
271 Tweets
511 Followers
271 Following
Another promising agent for #bloodpressure control in resistant #hypertension . In PRECISION trial, aprocitentan, a dual Endothelin antagonist, provided clinically meaningful lowering of BP over 48 weeks, with excess oedema and fluid retention though. thelancet.com/journals/lance…